-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
In 2015, Cooper's sales decreased by 13.
2%
year-on-year.
However, its net profit was essentially the same as in 2014 at $213 million
.
In the fourth quarter of 2015, Cooper's sales were $776 million, down 5.
4% year-over-year; Net income decreased 28%
year-over-year to $59.
3 million.
Its operating profit was $103 million, up 91%.
It is understood that in the American market, Cooper's sales in the fourth quarter reached 711 million US dollars, a year-on-year increase of 3.
2%; Shipments and operating profit increased by 3.
2% and 85.
4%
year-on-year.
Roy Armes, Chairman of Cooper, said: "2015 was very exciting for Cooper and we took many different steps around the world to strengthen our business capabilities
.
Cooper's full-year operating margin was nearly 12%, far exceeding the previous forecast
of 8%-10%.
”
Cooper claims that the company will continue to advance its strategic plans and investment business around the world in the future, and will increase investment in modern facilities, technology and product innovation
.
It is understood that excluding acquisition expenses, Cooper's capital expenditure in 2016 will reach US$240 million to US$260 million
.
